There are host of players which are already there with Diovan HCT, seven players are already there in the market with a combination, so upside for Ranbaxy will be limited, says Ranjit Kapadia of Centrum Broking Money Control, 2 months ago
Novartis CEO Joe Jimenez Take a look at Novartis' ($NVS) second-quarter results for reasons why it engineered that big asset swap-and-sale with GlaxoSmithKline ($GSK) and Eli Lilly ($LLY). The two units Novartis is unloading, vaccines and animal ...FiercePharma, 2 months ago
Doctors have long struggled to effectively treat heart failure caused by high blood pressure. ACE inhibitors, like enalapril -- formerly sold by Merck (NYSE: MRK However, despite those medicines being widely prescribed, and that means a greater ...Motley Fool, 2 weeks ago
JewishWorldReview.com | No matter how you get your insurance -- through your employer, from a state exchange, from an agent or directly from an insurance company -- you're paying a bigger share of your health-care costs than you used to. Higher ...Jewish World Review, 1 month ago
There has been little change in top-prescribed and top-selling prescription drugs in the United States, according to the latest data from research firm IMS Health. Hypothyroid medication levothyroxine ( Synthroid , AbbVie) continues to be the ...Medscape, 1 month ago
on your WebpageAdd Widget >Get your members hooked!